Eubiotics Global Market Report 2026

Eubiotics represent natural digestive feed supplements designed to enhance animal health and bolster immune system functionality. They incorporate a blend of food additives, including prebiotics, probiotics, and polysaccharides, aimed at supporting gut health, immune development, and maintaining optimal microflora in the gastrointestinal tract.

The primary categories of eubiotics encompass probiotics, prebiotics, organic acids, essential oils, and enzymes. Probiotics consist of live microorganisms that contribute to overall health, bolstering immunity and promoting digestive well-being. These microorganisms aid in improving immunity, digestion, gut health, and reducing microbial contamination. Eubiotics are available in various treatment forms such as dry and liquid formulations tailored for applications in livestock including cattle, poultry, swine, aquaculture, and other animals, catering to needs related to gut and digestive health, overall wellness, and immunity support in animals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the eubiotics market by increasing costs of imported microbial strains, fermentation substrates, enzymes, and encapsulation materials used in probiotic and prebiotic formulations. Livestock producers in North America and Europe are most affected due to reliance on imported specialty additives, while Asia-Pacific faces pricing pressure on export-oriented feed ingredients. These tariffs are increasing feed formulation costs and impacting adoption rates. At the same time, they are encouraging domestic fermentation capacity, regional strain development, and localized production of natural feed additives.

The eubiotics market research report is one of a series of new reports from The Business Research Company that provides eubiotics market statistics, including eubiotics industry global market size, regional shares, competitors with a eubiotics market share, detailed eubiotics market segments, market trends and opportunities, and any further data you may need to thrive in the eubiotics industry. This eubiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eubiotics market size has grown strongly in recent years. It will grow from $6.33 billion in 2025 to $6.88 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to restrictions on antibiotic growth promoters, increasing livestock production intensity, rising awareness of animal gut health, expansion of commercial feed manufacturing, availability of fermentation-based additives.

The eubiotics market size is expected to see strong growth in the next few years. It will grow to $9.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing demand for sustainable animal nutrition, rising focus on livestock immunity enhancement, expansion of aquaculture feed additives, growing investment in functional feed ingredients, increasing adoption of precision nutrition practices. Major trends in the forecast period include increasing adoption of natural gut health additives, rising demand for antibiotic-free animal nutrition, growing use of probiotic and prebiotic blends, expansion of species-specific feed solutions, enhanced focus on immunity-boosting feed formulations.

The rising demand for high-quality animal feeds is expected to drive the growth of the eubiotics market in the coming years. High-quality animal feeds are nutritionally balanced, contaminant-free formulations designed to meet animals' specific dietary needs, supporting optimal health, growth, and reproduction. Eubiotics are a key component of modern animal nutrition, increasingly used to enhance gut health, reduce reliance on antibiotics, and improve the sustainability of livestock production. For example, in 2023, according to the American Feed Industry Association, a US-based nonprofit representing the feed industry, nearly 5,650 animal food manufacturing facilities operated across the country, producing over 284 million tons of finished feed and pet food annually. Therefore, the growing demand for high-quality animal feeds is supporting the expansion of the eubiotics market.

Key companies in the market are focused on creating innovative products, such as prebiotic fiber, to gain a competitive edge and expand their customer base. Prebiotic fiber is a specialized type of fiber that encourages the growth of beneficial gut bacteria. For instance, in September 2023, Alltech, a U.S.-based nutrition company, launched Microbuild, an advanced prebiotic fiber designed to promote gut health and support a strong microbiome in pets. This innovative prebiotic aims to enhance overall well-being and ensure gut health, even when faced with bacterial challenges. It does so by increasing microbial diversity in the gut, thereby strengthening the animal's natural defenses. As a nutritional technology, Microbuild assists pets in developing a diverse and healthy microbiome, providing noticeable benefits for pet owners who witness improvements in their pets' health. The strength of Microbuild lies in prebiotics, specialized fibers that stimulate the growth of beneficial gut bacteria. Improved fiber digestibility not only aids in nutrient absorption and maintains intestinal integrity but also helps in developing a strong immune system. Microbuild is based on the advanced field of nutrigenomics, which investigates the complex relationship between genetics and nutrition.

In March 2024, Novus International, Inc., a U.S.-based global provider of innovative nutritional solutions, acquired BioResource International, Inc. for an undisclosed sum. Novus International aims to enhance its enzyme product portfolio, strengthen its innovation pipeline, improve supply chain management, support gut health initiatives, and better serve its customers in the animal nutrition sector. BioResource International, Inc. is a U.S.-based biotechnology company that develops enzyme products designed to improve animal nutrition, closely aligning with eubiotic principles to promote gut health in livestock.

Major companies operating in the eubiotics market are BASF SE, Koninklijke DSM NV, Lallemand Inc., Novus International Inc., Chr Hansen Holding A/S, Cargill Inc., Lesaffre Group, Kemin Industries Inc., Evonik Industries AG, Archer Daniels Midland Company, Beneo GmbH, BioResource International Inc., Biomin Holding GmbH, Bluestar Adisseo Company, Dupont Nutrition & Biosciences, Nutreco NV, Pancosma SA, Synbio Tech Inc., Vetagro SpA, Zinpro Corporation, Alltech Inc., Impextraco NV, Nuscience Group, Olmix Group

Europe was the largest region in the eubiotics market in 2025. The regions covered in the eubiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the eubiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The eubiotics market consists of sales of lactobacilli, bifidobacterium, streptococcus, fructo-oligosaccharides (FOS), inulin, galacto-oligosaccharides (GOS), and mannan-oligosaccharides (MOS). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eubiotics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses eubiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eubiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The eubiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Probiotics; Prebiotics; Organic Acids; Essential Oils
• 2) By Function: Gut And Digestive Health; General Health And Wellness; Immunity
• 3) By Form: Dry; Liquid
• 4) By Livestock: Cattle; Poultry; Swine; Aquaculture; Other Livestock
• Subsegments:
• 1) By Probiotics: Bacterial Probiotics; Yeast Probiotics
• 2) By Prebiotics: Fructooligosaccharides (FOS); Galactooligosaccharides (GOS); Inulin
• 3) By Organic Acids: Lactic Acid; Acetic Acid; Propionic Acid
• 4) By Essential Oils: Plant-Derived Essential Oils; Extracts With Antimicrobial Properties
• Companies Mentioned: BASF SE; Koninklijke DSM NV; Lallemand Inc.; Novus International Inc.; Chr Hansen Holding A/S; Cargill Inc.; Lesaffre Group; Kemin Industries Inc.; Evonik Industries AG; Archer Daniels Midland Company; Beneo GmbH; BioResource International Inc.; Biomin Holding GmbH; Bluestar Adisseo Company; Dupont Nutrition & Biosciences; Nutreco NV; Pancosma SA; Synbio Tech Inc.; Vetagro SpA; Zinpro Corporation; Alltech Inc.; Impextraco NV; Nuscience Group; Olmix Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Italy; Spain; Canada
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.